Xencor (XNCR) Amortizatization of Intangibles (2015 - 2026)

Xencor's (XNCR) quarterly Amortizatization of Intangibles came in at $128000.0 in Q1 2026, down 93.98% year-on-year from $2.1 million in Q1 2025, and down 62.35% on a QoQ basis from $340000.0 in Q4 2025.

Xencor (XNCR) Amortizatization of Intangibles (2015 - 2026) Analysis & Trends

Xencor (XNCR) has 12 years of Amortizatization of Intangibles data on file, last reported at $128000.0 in Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles fell 93.98% year-over-year to $128000.0 in Q1 2026; TTM through Mar 2026 was $1.5 million, a 86.83% decrease from a year earlier, with the FY2025 full-year figure at $3.5 million, down 78.3% from the prior year.
  • Amortizatization of Intangibles for Q1 2026 stood at $128000.0, down from $340000.0 in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for XNCR reached as high as $6.9 million in Q1 2024 and fell as low as -$637000.0 in Q2 2025.
  • Historically, Amortizatization of Intangibles has averaged $2.0 million across 5 years, with a median of $1.7 million in 2025.
  • Across the five-year window, Amortizatization of Intangibles soared 6452.54% in 2023 and slumped 113.19% in 2025, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at $782000.0 in 2022, then surged by 593.61% to $5.4 million in 2023, then tumbled by 110.9% to -$591000.0 in 2024, then jumped by 157.53% to $340000.0 in 2025, then plunged by 62.35% to $128000.0 in 2026.
  • Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $128000.0 in Q1 2026, $340000.0 in Q4 2025, and $1.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Xencor 1.49 Bn 1.11 Bn - 128,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 128,000.00
Mar 31, 2026 128,000.00
Dec 31, 2025 340,000.00
Dec 31, 2025 340,000.00
Sep 30, 2025 1.65 Mn
Sep 30, 2025 1.65 Mn
Jun 30, 2025 -637,000.00
Jun 30, 2025 -637,000.00
Mar 31, 2025 2.13 Mn
Mar 31, 2025 2.13 Mn
Dec 31, 2024 -591,000.00
Dec 31, 2024 -591,000.00
Sep 30, 2024 4.89 Mn
Sep 30, 2024 4.89 Mn
Jun 30, 2024 4.83 Mn
Jun 30, 2024 4.83 Mn
Mar 31, 2024 6.91 Mn
Mar 31, 2024 6.91 Mn
Dec 31, 2023 5.42 Mn
Dec 31, 2023 5.42 Mn